NDAINHALATIONAEROSOL, METERED
Approved
Jul 2020
Lifecycle
Peak
Competitive Pressure
0/100
Clinical Trials
1
Data completeness
7/8 — Comprehensive
BREZTRI AEROSPHERE (budesonide, glycopyrrolate, and formoterol fumarate) by AstraZeneca is adrenergic beta2-agonists [moa]. Approved for beta2-adrenergic agonist [epc]. First approved in 2020.
Drug data last refreshed 6h ago · AI intelligence enriched 8h ago
AI summarySynthesized from FDA + DailyMed + ClinicalTrials.gov data
Breztri Aerosphere is a fixed-dose combination inhaled therapy containing budesonide (corticosteroid), glycopyrrolate (anticholinergic), and formoterol (long-acting beta-2 agonist) for maintenance treatment of chronic obstructive pulmonary disease (COPD). The triple combination works synergistically to reduce airway inflammation, improve bronchodilation, and reduce exacerbations in moderate-to-severe COPD patients.
$0.796BPart D
Peak12.0 years to LOEPeak-stage product generating nearly $800M in Part D spending with ~1M claims annually, indicating a mature commercial team managing market dominance and maximizing penetration.
Mechanism of Action
Adrenergic beta2-Agonists
Pharmacologic Class:
beta2-Adrenergic Agonist
Indications
Indication data is being enriched from DailyMed and FDA labeling. Check back soon for approved therapeutic uses.
Clinical Trials (1)
Post-marketing Phase 4 Safety & Tolerability Study of Breztri aerosphereTM in Indian Patients With Chronic Obstructive Pulmonary Disease
Started Jan 2026
150 enrolled
Moderate to Severe COPD
Why This Matters for Your Career
Worked on BREZTRI AEROSPHERE at AstraZeneca? Share your interview experience or compensation data (+7 days Pro)
Data Sources
- Drug label: DailyMed / FDA
- Clinical trials: ClinicalTrials.gov
- Patent data: FDA Orange Book
- Spending data: CMS Medicare
The information on this page is for informational purposes only and should not be used as a substitute for professional medical advice. Drug information is sourced from FDA, DailyMed, and other government databases. Adverse event data from FAERS does not establish causation. Always consult a healthcare professional for medical decisions.